Literature DB >> 17303181

Abnormal hepatobiliary and circulating lipid metabolism in the Long-Evans Cinnamon rat model of Wilson's disease.

Emile Levy1, Sylvain Brunet, Fernando Alvarez, Ernest Seidman, Guylaine Bouchard, Enrique Escobar, Steve Martin.   

Abstract

Long-Evans Cinnamon (LEC) rats exhibit a genetic defect in Atp7b gene, which is homologous to the human Wilson's disease gene, resulting in an inability to mobilize copper from the liver. This study was undertaken to gain insight into the relationship between liver copper accumulation and plasma lipid profile, circulating lipoprotein composition, hepatic sterol metabolism and biliary lipid secretion rates in 12-week-old LEC rats compared to control Long-Evans rats. Concomitant with hepatic copper deposition, LEC rats displayed increased content of triglycerides (TGs), free cholesterol (FC) and cholesteryl ester (CE) in the liver. Hepatic concentrations of malondialdehyde (MDA), an index of lipid peroxidation were also significantly elevated in LEC rats (50%). This steatosis was associated with aberrant microsomal apolipoprotein (apo) B-100 and microsomal triglyceride transfer protein (MTP) content, hypotriglyceridemia, hypocholesterolemia and abnormalities in both circulating lipoprotein composition and size. Atypical hepatobiliary sterol metabolism was established by the assessment of the activity of key intracellular enzymes for cholesterol homeostasis, which demonstrated, with respect to controls, a 40% reduction in 3-hydroxy-3-methylglutaryl coenzyme A reductase, a 30% reduction in cholesterol 7alpha-hydroxylase, and a 54% reduction in acyl CoA:cholesterol acyltransferase. During a 6-h biliary drainage, a decline in the bile acid output was recorded and might be linked to the low protein expression of the bile salt export pump (BSEP or ABCB11). Our data emphasize the crucial role of copper balance in hepatic sterol homeostasis and lipoprotein metabolism in LEC rats. Additional studies are needed to delineate the mechanisms of these disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17303181     DOI: 10.1016/j.lfs.2007.01.017

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

Review 1.  Animal models of Wilson disease.

Authors:  Emily Reed; Svetlana Lutsenko; Oliver Bandmann
Journal:  J Neurochem       Date:  2018-06-26       Impact factor: 5.372

2.  Adipocyte-specific disruption of ATPase copper transporting α in mice accelerates lipoatrophy.

Authors:  Cong Tao; Yajun Wang; Ying Zhao; Jianfei Pan; Yiping Fan; Xiaojuan Liang; Chunwei Cao; Jianguo Zhao; Michael J Petris; Kui Li; Yanfang Wang
Journal:  Diabetologia       Date:  2019-08-08       Impact factor: 10.122

Review 3.  Systems biology approach to Wilson's disease.

Authors:  Jason L Burkhead; Lawrence W Gray; Svetlana Lutsenko
Journal:  Biometals       Date:  2011-03-05       Impact factor: 2.949

4.  Bile salt-induced pro-oxidant liver damage promotes transplanted cell proliferation for correcting Wilson disease in the Long-Evans Cinnamon rat model.

Authors:  Brigid Joseph; Sorabh Kapoor; Michael L Schilsky; Sanjeev Gupta
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

5.  Oxidative stress and mitochondrial functions in the intestinal Caco-2/15 cell line.

Authors:  Rame Taha; Ernest Seidman; Genevieve Mailhot; François Boudreau; Fernand-Pierre Gendron; Jean-François Beaulieu; Daniel Ménard; Edgard Delvin; Devendra Amre; Emile Levy
Journal:  PLoS One       Date:  2010-07-27       Impact factor: 3.240

6.  Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress.

Authors:  Shinichiro Hanada; Natasha T Snider; Elizabeth M Brunt; Paul F Hollenberg; M Bishr Omary
Journal:  Gastroenterology       Date:  2010-01-11       Impact factor: 22.682

7.  Alterations of lipid metabolism in Wilson disease.

Authors:  Jessica Seessle; Annina Gohdes; Daniel Nils Gotthardt; Jan Pfeiffenberger; Nicola Eckert; Wolfgang Stremmel; Ulrike Reuner; Karl Heinz Weiss
Journal:  Lipids Health Dis       Date:  2011-05-19       Impact factor: 3.876

Review 8.  Wilson's disease: a comprehensive review of the molecular mechanisms.

Authors:  Fei Wu; Jing Wang; Chunwen Pu; Liang Qiao; Chunmeng Jiang
Journal:  Int J Mol Sci       Date:  2015-03-20       Impact factor: 5.923

9.  Activation of liver X receptor/retinoid X receptor pathway ameliorates liver disease in Atp7B(-/-) (Wilson disease) mice.

Authors:  James P Hamilton; Lahari Koganti; Abigael Muchenditsi; Venkata S Pendyala; David Huso; Joseph Hankin; Robert C Murphy; Dominik Huster; Uta Merle; Christopher Mangels; Nan Yang; James J Potter; Esteban Mezey; Svetlana Lutsenko
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

10.  Protective effect of the omega-3 polyunsaturated fatty acids: Eicosapentaenoic acid/Docosahexaenoic acid 1:1 ratio on cardiovascular disease risk markers in rats.

Authors:  Laura Lluís; Núria Taltavull; Mònica Muñoz-Cortés; Vanesa Sánchez-Martos; Marta Romeu; Montse Giralt; Eunice Molinar-Toribio; Josep Lluís Torres; Jara Pérez-Jiménez; Manuel Pazos; Lucía Méndez; José M Gallardo; Isabel Medina; M Rosa Nogués
Journal:  Lipids Health Dis       Date:  2013-10-01       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.